MY151447A - Intravenous injection of non-neurotoxic plasminogen activators for the treatment of stroke - Google Patents

Intravenous injection of non-neurotoxic plasminogen activators for the treatment of stroke

Info

Publication number
MY151447A
MY151447A MYPI20041567A MYPI20041567A MY151447A MY 151447 A MY151447 A MY 151447A MY PI20041567 A MYPI20041567 A MY PI20041567A MY PI20041567 A MYPI20041567 A MY PI20041567A MY 151447 A MY151447 A MY 151447A
Authority
MY
Malaysia
Prior art keywords
stroke
treatment
intravenous injection
plasminogen activators
neurotoxic plasminogen
Prior art date
Application number
MYPI20041567A
Inventor
Söhngen Mariola
Söhngen Wolfgang
Schleuning Wolf-Dieter
Medcalf Robert
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of MY151447A publication Critical patent/MY151447A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49—Urokinase; Tissue plasminogen activator
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A61K38/58—Protease inhibitors from animals; from humans from leeches, e.g. hirudin, eglin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Zoology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

THE INVENTION REFERS TO THE USE OF NON-NEUROTOXIC PLASMINOGEN ACTIVATING FACTORS, E.G. FROM DESMODUS ROTUNDUS (DSPA) OR OF GENETICALLY MODIFIED PLASMINOGEN ACTIVATING FACTORS, IN PARTICULAR OF HUMAN ORIGIN, FOR THE PRODUCTION OF A PHARMACEUTICAL FOR INJECTION FOR THE THERAPEUTIC TREATMENT OF STROKE IN HUMANS.
MYPI20041567A 2003-05-02 2004-04-30 Intravenous injection of non-neurotoxic plasminogen activators for the treatment of stroke MY151447A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EPPCT/EP03/04608 2003-05-02
PCT/EP2003/004729 WO2004096267A1 (en) 2003-05-02 2003-05-06 Intravenous injection of non-neurotoxic plasminogen activators for the treatment of stroke

Publications (1)

Publication Number Publication Date
MY151447A true MY151447A (en) 2014-05-30

Family

ID=33395696

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI20041567A MY151447A (en) 2003-05-02 2004-04-30 Intravenous injection of non-neurotoxic plasminogen activators for the treatment of stroke

Country Status (13)

Country Link
JP (1) JP2012077090A (en)
CN (1) CN1849133B (en)
AU (3) AU2003227721A1 (en)
CY (1) CY1114254T1 (en)
DK (1) DK1622639T3 (en)
EA (2) EA201000501A1 (en)
ES (1) ES2401782T3 (en)
IL (1) IL171636A (en)
MY (1) MY151447A (en)
PT (1) PT1622639E (en)
SI (1) SI1622639T1 (en)
WO (1) WO2004096267A1 (en)
ZA (2) ZA200703704B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10153601A1 (en) 2001-11-02 2003-05-22 Paion Gmbh DSPA for the treatment of stroke
TWI445540B (en) 2007-04-20 2014-07-21 Ajinomoto Kk Anti-hypothermia composition
AR067345A1 (en) * 2007-07-10 2009-10-07 Paion Deutschland Gmbh USE OF THROMBOMODULIN FOR THE PREPARATION OF A THROMBOLITIC MEDICINAL PRODUCT
EP2014296A1 (en) * 2007-07-10 2009-01-14 PAION Deutschland GmbH Novel strategies for increasing the reperfusion in obstructed blood vessel

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK176140B1 (en) * 1988-07-20 2006-09-25 Schering Ag Patentabteilung Bat salivary plasminogen activators
NL8902454A (en) * 1989-10-03 1991-05-01 Stichting Centraal Lab MUTANTS OF THE HUMANE PLASMINOGENIC ACTIVATOR INHIBITOR 1 (PAI-1), THEIR PREPARATION AND USE, AND RECOMBINANT POLYNUCLEOTIDES INCLUDING GENETIC INFORMATION CODING FOR THESE MUTANTS.
DE69226580T2 (en) * 1991-09-05 1999-03-04 Schering Ag, 13353 Berlin Inhibitor of collagen-induced platelet aggregation
DE10153601A1 (en) * 2001-11-02 2003-05-22 Paion Gmbh DSPA for the treatment of stroke

Also Published As

Publication number Publication date
JP2012077090A (en) 2012-04-19
IL171636A (en) 2013-07-31
AU2004233601B2 (en) 2009-11-26
EA200501733A1 (en) 2006-06-30
EA013837B1 (en) 2010-08-30
SI1622639T1 (en) 2013-05-31
ZA200703704B (en) 2008-08-27
AU2003227721A1 (en) 2004-11-23
CN1849133B (en) 2011-03-30
ES2401782T3 (en) 2013-04-24
AU2004233601A1 (en) 2004-11-11
EA201000501A1 (en) 2010-10-29
HK1092045A1 (en) 2007-02-02
CN1849133A (en) 2006-10-18
DK1622639T3 (en) 2013-04-15
CY1114254T1 (en) 2016-08-31
PT1622639E (en) 2013-04-01
AU2010200718A1 (en) 2010-03-18
ZA200509053B (en) 2007-11-28
WO2004096267A1 (en) 2004-11-11

Similar Documents

Publication Publication Date Title
CY1109648T1 (en) NON-NEUROTOTOXIC PLASMINOGEN ACTIVATORS FACTORS FOR BRAIN INTERVENTION
DE60111570D1 (en) ISOINDOLIN-1-ON AS GLUCOKINASE ACTIVATORS
TW200510325A (en) 2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof
DE60021254D1 (en) N-cyanomethylamide als protease inhibitoren
WO2003032994A3 (en) Novel tri-substituted pyrimidines, method for production and use thereof as medicament
TW200744642A (en) Novel peptides for use in the treatment of obesity
MXPA05008406A (en) Phenylacetamides and their use as glucokinase modulators.
IL171607A (en) Use of a botulinum toxin for the preparation of a medicament for treating sinus headache
WO2004096268A3 (en) Intravenous injection of plasminogen non-neurotoxic activators for treating cerebral stroke
HRP20041071A2 (en) Methods of treating hepatitis
MX2007003907A (en) Therapeutic agents with decreased toxicity.
MXPA05011233A (en) Somatostatin vectors.
YU68702A (en) Novel lhrh-antagonists, production and use thereof as medicament
MXPA05012675A (en) Hydroxyamidine and hydroxyguanidine compounds as urokinase inhibitors.
WO2003039539A3 (en) Use of endothelin receptor antagonists in the treatment of tumour diseases
GB2446341A (en) Method and system for transdermal drug delivery
CY1114254T1 (en) Intravenous injection of non-neurotoxic plasminogen activators to treat cerebral episode
EP4487909A3 (en) Therapeutic uses of glucokinase activators in combination with insulin or insulin analogs
AU6011001A (en) Novel lhrh-antagonists, production and use thereof as medicament
UA90504C2 (en) Novel drugs for treating respiratory diseases
MXPA03008406A (en) Novel medicament compositions based on anticholinergic agents and endothelin antagonists.
EA200801077A1 (en) ANTAGONISTS OF PF4 AND RANTES INTERACTIONS
UA90843C2 (en) Tri(cyclo) substituted amide compounds
MX2007004040A (en) Novel use of -sympathomimetics having a 2-imidazoline structure.
RU2007120403A (en) METHOD FOR LOCAL THERAPY OF AUTOIMMUNE ARTHRITIS